STOCK TITAN

[Form 4] CeriBell, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) director and President & CEO Jane (Xingjuan) Chao reported a sale of 2,887 shares of common stock on 08/25/2025 at a price of $11.58 per share. After the sale, the filing shows Ms. Chao directly beneficially owns 773,135 shares. The report also discloses an indirect interest of 369,088 shares held by the ACP 2021 Trust, for which she is a co-trustee and from which she disclaims beneficial ownership except to the extent of her pecuniary interest.

The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing records a routine disposition of shares by an insider who holds substantial direct and indirect positions, and it includes the required explanatory note about the trustee relationship and disclaimer of beneficial ownership.

Ceribell, Inc. (CBLL) direttrice e Presidente e CEO Jane (Xingjuan) Chao ha comunicato la vendita di 2.887 azioni ordinarie in data 25/08/2025 al prezzo di $11,58 per azione. Dopo la vendita, la segnalazione indica che la Sig.ra Chao possiede direttamente 773.135 azioni. Il rapporto riporta inoltre un interesse indiretto di 369.088 azioni detenute dall'ACP 2021 Trust, per il quale è co-trustee e del quale dichiara di non essere beneficiaria salvo per la misura del suo interesse patrimoniale.

Il Modulo 4 è stato firmato da un avvocato con procura in data 27/08/2025. La registrazione documenta una normale cessione di azioni da parte di un insider che detiene posizioni rilevanti dirette e indirette e include la nota esplicativa richiesta riguardo al rapporto con il trustee e alla dichiarazione di non titolarità beneficiaria.

Ceribell, Inc. (CBLL) directora y Presidenta y CEO Jane (Xingjuan) Chao informó la venta de 2.887 acciones ordinarias el 25/08/2025 a un precio de $11,58 por acción. Tras la venta, el informe muestra que la Sra. Chao posee directamente 773.135 acciones. El reporte también revela un interés indirecto de 369.088 acciones en la ACP 2021 Trust, de la que es co-fiduciaria y de la que reniega la propiedad beneficiaria salvo en la medida de su interés pecuniario.

El Formulario 4 fue firmado por un apoderado el 27/08/2025. La presentación registra una disposición rutinaria de acciones por parte de un insider con posiciones directas e indirectas sustanciales e incluye la nota explicativa requerida sobre la relación con el fideicomiso y la renuncia a la titularidad beneficiaria.

Ceribell, Inc. (CBLL) 이사이자 사장 겸 CEO인 Jane(성: Xingjuan) Chao는 2025-08-25에 보통주 2,887주를 주당 $11.58에 매도했다고 보고했습니다. 매도 후 Chao 씨는 직간접 소유를 포함해 직접 773,135주를 보유하고 있는 것으로 신고되었습니다. 보고서에는 그녀가 공동수탁자(co-trustee)로 있는 369,088주의 간접적 이익이 ACP 2021 Trust에 의해 보유되어 있으며, 그녀는 금전적 이익 범위를 제외하고는 수익적 소유권을 부인한다고 명시되어 있습니다.

해당 Form 4는 2025-08-27에 대리인(변호사)에 의해 서명되었습니다. 이 제출서는 상당한 직접 및 간접 보유를 가진 내부자의 통상적인 주식 처분을 기록하고 있으며, 수탁자 관계 및 수익적 소유권 부인에 대한 필수 설명을 포함하고 있습니다.

Ceribell, Inc. (CBLL) administratrice et Présidente & CEO Jane (Xingjuan) Chao a déclaré la vente de 2 887 actions ordinaires le 25/08/2025 au prix de 11,58 $ par action. Après la vente, la déclaration indique que Mme Chao détient directement 773 135 actions. Le rapport révèle également un intérêt indirect de 369 088 actions détenues par l'ACP 2021 Trust, dont elle est co-trustee et dont elle décline la qualité de bénéficiaire sauf dans la mesure de son intérêt pécuniaire.

Le formulaire 4 a été signé par un mandataire le 27/08/2025. Le dépôt enregistre une cession routinière d'actions par un initié détenant des positions directes et indirectes substantielles et inclut la note explicative requise concernant la relation avec le trustee et la dénégation de la qualité de bénéficiaire.

Ceribell, Inc. (CBLL)-Direktorin sowie Präsidentin und CEO Jane (Xingjuan) Chao meldete den Verkauf von 2.887 Stammaktien am 25.08.2025 zu einem Preis von $11,58 je Aktie. Nach dem Verkauf weist die Meldung aus, dass Frau Chao direkt 773.135 Aktien besitzt. Der Bericht offenbart zudem ein indirektes Interesse von 369.088 Aktien, gehalten vom ACP 2021 Trust, bei dem sie Mittreuhänderin ist und dessen wirtschaftliche Eigentümerschaft sie nur insoweit bestreitet, wie es ihr pecuniäres Interesse betrifft.

Das Formular 4 wurde am 27.08.2025 von einem Bevollmächtigten unterzeichnet. Die Einreichung dokumentiert eine routinemäßige Veräußerung von Aktien durch einen Insider mit erheblichen direkten und indirekten Positionen und enthält den erforderlichen erläuternden Hinweis zur Treuhänderbeziehung und zum Hinweis auf die Nicht-Inhaberschaft des wirtschaftlichen Eigentums.

Positive
  • Transparent disclosure of insider transaction with transaction date, price, and post-transaction direct holdings
  • Clear explanation of indirect holdings via the ACP 2021 Trust and a disclaimer of beneficial ownership, which aids investor understanding
Negative
  • No indication on the form that the sale was made under a pre-arranged 10b5-1 trading plan (box not checked), leaving the motive unspecified

Insights

TL;DR: Insider sale by the CEO/director is routine disclosure; co-trustee status explains indirect holdings and a disclaimer is standard.

The reported sale of 2,887 shares at $11.58 by the reporting person—who serves as both President & CEO and a director—appears to be a routine disposition rather than a structural change in control. The filing properly identifies both direct and indirect holdings and includes the co-trustee explanatory language, which clarifies the scope of claimed beneficial ownership. From a governance perspective, accurate Form 4 reporting preserves transparency; the presence of sizable direct and trust-held positions underscores alignment with shareholders but also concentrates insider exposure.

TL;DR: Small insider sale relative to total holdings; transaction itself is unlikely to be market-moving.

The disposition of 2,887 shares at $11.58 is modest compared with the reported direct holding of 773,135 shares and the 369,088 shares associated with the ACP 2021 Trust. The Form 4 discloses transaction details clearly, including the reporting person’s dual roles and trustee relationship. There is no additional transactional context such as a 10b5-1 plan indicated on the form, and no derivative transactions are reported. Based solely on the disclosed numbers, the sale is immaterial to company capitalization and likely reflects a personal liquidity event rather than corporate action.

Ceribell, Inc. (CBLL) direttrice e Presidente e CEO Jane (Xingjuan) Chao ha comunicato la vendita di 2.887 azioni ordinarie in data 25/08/2025 al prezzo di $11,58 per azione. Dopo la vendita, la segnalazione indica che la Sig.ra Chao possiede direttamente 773.135 azioni. Il rapporto riporta inoltre un interesse indiretto di 369.088 azioni detenute dall'ACP 2021 Trust, per il quale è co-trustee e del quale dichiara di non essere beneficiaria salvo per la misura del suo interesse patrimoniale.

Il Modulo 4 è stato firmato da un avvocato con procura in data 27/08/2025. La registrazione documenta una normale cessione di azioni da parte di un insider che detiene posizioni rilevanti dirette e indirette e include la nota esplicativa richiesta riguardo al rapporto con il trustee e alla dichiarazione di non titolarità beneficiaria.

Ceribell, Inc. (CBLL) directora y Presidenta y CEO Jane (Xingjuan) Chao informó la venta de 2.887 acciones ordinarias el 25/08/2025 a un precio de $11,58 por acción. Tras la venta, el informe muestra que la Sra. Chao posee directamente 773.135 acciones. El reporte también revela un interés indirecto de 369.088 acciones en la ACP 2021 Trust, de la que es co-fiduciaria y de la que reniega la propiedad beneficiaria salvo en la medida de su interés pecuniario.

El Formulario 4 fue firmado por un apoderado el 27/08/2025. La presentación registra una disposición rutinaria de acciones por parte de un insider con posiciones directas e indirectas sustanciales e incluye la nota explicativa requerida sobre la relación con el fideicomiso y la renuncia a la titularidad beneficiaria.

Ceribell, Inc. (CBLL) 이사이자 사장 겸 CEO인 Jane(성: Xingjuan) Chao는 2025-08-25에 보통주 2,887주를 주당 $11.58에 매도했다고 보고했습니다. 매도 후 Chao 씨는 직간접 소유를 포함해 직접 773,135주를 보유하고 있는 것으로 신고되었습니다. 보고서에는 그녀가 공동수탁자(co-trustee)로 있는 369,088주의 간접적 이익이 ACP 2021 Trust에 의해 보유되어 있으며, 그녀는 금전적 이익 범위를 제외하고는 수익적 소유권을 부인한다고 명시되어 있습니다.

해당 Form 4는 2025-08-27에 대리인(변호사)에 의해 서명되었습니다. 이 제출서는 상당한 직접 및 간접 보유를 가진 내부자의 통상적인 주식 처분을 기록하고 있으며, 수탁자 관계 및 수익적 소유권 부인에 대한 필수 설명을 포함하고 있습니다.

Ceribell, Inc. (CBLL) administratrice et Présidente & CEO Jane (Xingjuan) Chao a déclaré la vente de 2 887 actions ordinaires le 25/08/2025 au prix de 11,58 $ par action. Après la vente, la déclaration indique que Mme Chao détient directement 773 135 actions. Le rapport révèle également un intérêt indirect de 369 088 actions détenues par l'ACP 2021 Trust, dont elle est co-trustee et dont elle décline la qualité de bénéficiaire sauf dans la mesure de son intérêt pécuniaire.

Le formulaire 4 a été signé par un mandataire le 27/08/2025. Le dépôt enregistre une cession routinière d'actions par un initié détenant des positions directes et indirectes substantielles et inclut la note explicative requise concernant la relation avec le trustee et la dénégation de la qualité de bénéficiaire.

Ceribell, Inc. (CBLL)-Direktorin sowie Präsidentin und CEO Jane (Xingjuan) Chao meldete den Verkauf von 2.887 Stammaktien am 25.08.2025 zu einem Preis von $11,58 je Aktie. Nach dem Verkauf weist die Meldung aus, dass Frau Chao direkt 773.135 Aktien besitzt. Der Bericht offenbart zudem ein indirektes Interesse von 369.088 Aktien, gehalten vom ACP 2021 Trust, bei dem sie Mittreuhänderin ist und dessen wirtschaftliche Eigentümerschaft sie nur insoweit bestreitet, wie es ihr pecuniäres Interesse betrifft.

Das Formular 4 wurde am 27.08.2025 von einem Bevollmächtigten unterzeichnet. Die Einreichung dokumentiert eine routinemäßige Veräußerung von Aktien durch einen Insider mit erheblichen direkten und indirekten Positionen und enthält den erforderlichen erläuternden Hinweis zur Treuhänderbeziehung und zum Hinweis auf die Nicht-Inhaberschaft des wirtschaftlichen Eigentums.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chao Xingjuan

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 F 2,887 D $11.58 773,135 D
Common Stock 369,088 I By ACP 2021 Trust(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Ceribell (CBLL) insider Jane Chao report on 08/25/2025?

The Form 4 reports a sale of 2,887 shares of Ceribell common stock at $11.58 per share on 08/25/2025.

How many Ceribell shares does Jane Chao directly own after the reported sale?

Following the reported transaction, the filing shows Ms. Chao directly beneficially owns 773,135 shares.

Does Jane Chao have any indirect holdings in CBLL?

Yes. The Form 4 discloses an indirect interest of 369,088 shares held by the ACP 2021 Trust, of which she is a co-trustee.

Did the Form 4 indicate the sale was made under a 10b5-1 trading plan?

No. The form does not indicate that the transaction was pursuant to a 10b5-1 plan (the relevant box is not checked).

Who signed the Form 4 for Jane Chao?

The Form 4 was signed by Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao on 08/27/2025.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

419.44M
28.88M
10.39%
84.32%
3.46%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE